Format

Send to

Choose Destination
Clin Pharmacol Ther. 2014 Jun;95(6):581-2. doi: 10.1038/clpt.2014.65.

The ISoP Standards and Best Practices Committee.

Author information

1
Pharsight Consulting Services, Pharsight-a Certara Company, Marseille, France.
2
Infection, Antimicrobials, Modelling, Evolution (IAME), UMR 1137, INSERM and University Paris Diderot, Paris, France.
3
Astellas Pharma Global Development, Northbrook, Illinois, USA.
4
Division of Pharmacometrics, Office of Clinical Pharmacology, US Food and Drug Administration, Silver Spring, Maryland, USA.
5
Pfizer Global Research, Groton, Connecticut, USA.
6
University at Buffalo, State University of New York, Buffalo, New York, USA.

Abstract

The mission of the International Society of Pharmacometrics (ISoP) Standards and Best Practices Committee is to provide best practices and recommendations for standard pharmacometric analyses-e.g., population pharmacokinetics/pharmacodynamics (PK/PD), exposure-response, disease models-with the goal of increasing consistency, productivity, quality, communication, and impact of pharmacometrics on decision making. We present the progress and plans of the committee and call for volunteers to start new initiatives.

PMID:
24842638
DOI:
10.1038/clpt.2014.65
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center